{
  "created_at": "Tue Jan 18 2:57:57 +0000 2022",
  "id_str": "1483164989162770440",
  "full_text": "A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday. $PFE",
  "display_text_range": [
    0,
    195
  ],
  "entities": {
    "hashtags": [],
    "symbols": [
      {
        "text": "PFE",
        "indices": [
          191,
          195
        ]
      }
    ],
    "user_mentions": [],
    "urls": []
  },
  "user": {
    "name": "The_Real_Fly",
    "screen_name": "The_Real_Fly",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1365459205453471751/LL4GKo3m_normal.jpg"
  },
  "retweet_count": 48,
  "favorite_count": 209,
  "original_created_at": "Mon Jan 17 19:51:03 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "月曜日に発表されたイスラエルでの試験の予備データによると、ファイザーとバイオテックワクチンの4回目の投与では、Covid-19のomicron変異体による感染を防ぐには不十分であった。PFE"
    },
    {
      "locale": "zh",
      "full_text": "根据周一发布的以色列一项试验的初步数据，辉瑞-生物技术公司的第四剂疫苗不足以预防Covid-19的omicron变体感染。$PFE"
    },
    {
      "locale": "zh-Hant",
      "full_text": "根據週一發佈的以色列一項試驗的初步數據，輝瑞-生物技術公司的第四劑疫苗不足以預防Covid-19的omicron變體感染。$PFE"
    }
  ]
}